PharmFest 2010 Spotlights Pharmaceutical Life Sciences

Emerging issues and future trends in the pharmaceutical life sciences are discussed by experts

Photo: Mike Peters

The PharmFest 2010 Opening Panel participants were (from left) Frank Ciriello, Senior VP, Eisai Corporation of North America; Ronald M. Califre, Senior VP, Novartis Pharmaceutical Corporation; Bradley Sheares, Former CEO, Reliant Pharmaceuticals, Inc. and former President of US Human Health, Merck; and Mark E. Kolb, Senior VP and Head, Patni Life Sciences.

New Jersey’s pharmaceutical and health care industry leaders, prominent scientists and academics, and Montclair State University faculty, administrators, and students gathered together at the University Hall Conference Center on April 12 for PharmFest 2010, the day-long conference that has become the state’s leading forum for the exploration and discussion of matters relating to the pharmaceutical life sciences.

Co-sponsored by Montclair State University and the HealthCare Institute of New Jersey, the biennial event is designed to broaden awareness of the current and future state of the pharmaceutical life sciences through presentations, panel discussions, and workshops; networking opportunities for industry attendees; and career insights for students interested in working in pharmaceutical, biotechnology and health-related fields.

“PharmFest offers students, faculty, professional and other interested community members a chance to explore and learn about emerging issues and trends in the pharmaceutical industry,” said Robert Prezant, dean of Montclair State University’s College of Science and Mathematics. “It gives our students, in particular, a chance to meet leading executives in pharmaceutical research and business to discuss the ongoing evolution and the future of the pharmaceutical and life science industries.”

Indeed, students comprised the largest segment of the audience in each of the sessions, many of which were standing-room-only. In addition to the opening panel discussion, “Emerging Issues in Pharma,” and the keynote address, “Advancing the State of Biotechnology,” which was delivered by Debbie Hart, president of BioNJ, the session topics included “Veterans’ Health Issues,” “Green Chemistry,” “Global Health,” “Preventive/Holistic Medicine,” Pharmacogenomics,” and “Diverse Careers in Pharma.”

The event was a great success thanks to the many prominent pharmaceutical, healthcare, and academic leaders who participated in the sessions, and the collaborative organizational work of Montclair State’s College of Science and Mathematics, The School of Business, and the Center for Career Services and Cooperative Education.

“With over 200 participants at PharmFest 2010, it is obvious that the state of pharma in New Jersey remains a topic of keen interest,” noted Prezant. “And as the industry reformulates, and as we heard at this symposium, it is equally clear that the pharmaceutical and health industry will remain a vital component of the intellectual and economic engine that helps drive our state.”

See more photos from the event.

View a WMBC News clip of  the event.

Media: